Although generally considered safe for most people when used appropriately, its safety can depend on the method of use and individual health factors
[137] Cost, coverage and supply [edit] In 2023, Ozempic, the semaglutide injection used for type 2 diabetes treatment, had list price of one-month supply of $936 in the US, $169 in Japan, $147 in Canada, $144 in Switzerland, $103 in Germany and the Netherlands, $96 in Sweden, $93 in the UK, and $87 in Australia
24 months from the date of Manufacturing
These findings highlight the substantial weight-lowering effect of retatrutide, even in a relatively short treatment period and in people with T2D